A Partner Blog from Three of the Tarsus Family of Brands: American Academy of Anti-Aging Medicine, Cardiometabolic Health Congress, and LiVDerm.
A review published in May 2021 in the European Cardiology Review sought to elucidate the various potential factors, mechanisms, or processes linking cardiovascular disease (CVD) and psoriasis. Observational relationships between these two diseases include: an increased independent association between cardiovascular disease and severe psoriasis in younger patients; a higher mortality rate in patients with psoriasis with an overall five-year reduction in life expectancy; a parallel rise in psoriasis severity and CVD risk factors such as hypertension, diabetes, hyperlipidemia, and nonalcoholic fatty liver disease; a higher rate of both CVD and psoriasis in geographical populations furthest from the equator; and the majority of deaths in patients with psoriasis being attributed to cardiovascular or cerebrovascular events. The authors of the review noted that severe psoriasis was more strongly linked to cardiovascular-related mortality than was mild or moderate psoriasis.
